3 results
Approved WMOCompleted
The objective of this trial is to evaluate the activity and safety of Brostallicin used as first line chemotherapy in patients with advanced or metastatic soft tissue sarcoma.
Approved WMOPending
The results of this study will give better insights in the role of ADMA in the development of systemic endothelial dysfunction.
Approved WMORecruiting
The results of this study will give better insights in the role of ADMA in the development of systemicendothelial dysfunction and the relation with mild renal insufficiency.